CCL2 and cardiac hypertrophy: Although no significant differences were observed between wild type and MCP-1 knockout mice in over a 6-week course of Ang II infusion in cardiac hypertrophy, MCP-1 deficiency suppressed inflammatory cytokine production and reduced fibrosis during early stages (132).